Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06225752 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Probucol for Symptomatic Intracranial and Extracranial Artery Stenosis

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 15, 2024 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 1, 2024 to Jun 15, 2024
    • Site details revised
    v3
  2. Secondary endpoints: details revised at 1 of 4 entriesv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is a multicenter, double-blind, placebo-controlled, randomized clinical trial that aims to evaluate the efficacy of probucol on the reduction of the risk of recurrent stroke in patients with symptomatic intracranial or extracranial arterial stenosis.
Trial Details
NCT Number NCT06225752
Lead Sponsor First Affiliated Hospital of Wannan Medical College
Collaborators: Beijing Tiantan Hospital
Conditions
(from sponsor)		 Ischemic Stroke, TIA
Related terms Ischemic Stroke, Stroke
Enrollment 5,452 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov